Brief: Firebrick Pharma Says New Agreement Allows Nasodine Launch In Philippines
15/08/2024 03:05
Aug 15 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* NEW AGREEMENT ALLOWS NASODINE LAUNCH IN PHILIPPINES
* EXECUTED AMENDED AGREEMENT WITH EXISTING MARKETING PARTNER
IN
PHILIPPINES, S.V. MORE PHARMA CORPORATION
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement